New drugs take aim at hepatitis C, spur debate on whether to test baby boomers

WASHINGTON - There's new hope for an overlooked epidemic: Two powerful drugs are nearing the market that promise to help cure many more people of liver-attacking hepatitis C — even though most who have the simmering infection don't know it yet....More